Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Breast 6Genitourinary 5Tumor-Agnostic 3Other 3Lymphoid 3Thoracic 2Sarcoma 2Head & Neck 2Other hematologic neoplasm 1Gynecologic 1Endocrine 1CNS 1

Conditions

Urinary Incontinence, Stress 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Electroacupuncture × Endocrine × Clear all
NCT05773716 2025-07-24

Electroacupuncture and Pelvic Floor Muscle Training for Male Stress Urinary Incontinence

RenJi Hospital

Phase NA Completed
120 enrolled
Endocrine

Urinary Incontinence, Stress, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡